Rachel Klemovitch, Assistant Editor02.28.24
GE HealthCare and Biofourmis have entered a strategic collaboration to make home care more accessible and safer. The collaboration aims to offer more patients an alternative to facility-based care so that patients can leave hospitals earlier while receiving care that can be remotely managed.
Starting in the first quarter of 2024, GE HealthCare will begin distributing Biofourmis solutions within the US.
Hospitals have recently reported experiencing increased cost of care and readmission rates due to workforce shortages and limited bed capacities. At-home care programs are designed to support patient recovery while reducing hospital readmission rates. These programs also showed that patients are three times more likely to be satisfied with the overall experience I,VI.
Biofourmis’ FDA-cleared AI-guided algorithms and GE’s monitoring solutions can help provide efficient and personalized home care.
Biofourmis solutions enable care in person and virtually through its digital platform. The company offers clinical-grade wearable devices, at-home services orchestration technology, and nursing services.
GE HealthCare’s FlexAcuity monitoring solutions and its Mural ICU virtual care solutions are adapting to patient needs in the hospital. In offering Biofourmis virtual care-at-home solutions, GE can offer care beyond the hospital.
“Biofourmis’ demonstrated success with care-at-home solutions will extend GE HealthCare’s current inpatient monitoring portfolio to support patient care from the hospital to home,” said GE HealthCare’s global general manager of cardiology solutions, Ashutosh Banerjee. “Combining our companies’ demonstrated capabilities will help revolutionize the way we approach the patient care journey as well as help address current challenges faced by health systems including hospital capacity issues and clinical staffing shortages.”
Ross Armstrong, General Manager of Biofourmis Care, said: “Our collaboration will enable health systems and hospitals to leverage the power of technology and data in order to shape patient-focused solutions across the care continuum, no matter where the site of care is.”
Resources:
[i] Fleron, A., Krishna, A., & Singhal, S. (2022, September 19). The gathering storm: The transformative impact of inflation on the healthcare sector. McKinsey & Company. https://www.mckinsey.com/industries/healthcare/our-insights/the-gathering-storm-the-transformative-impact-of-inflation-on-the-healthcare-sector
[vi] Leff B, Burton L, Mader S, Naughton B, Burl J, Clark R, Greenough WB 3rd, Guido S, Steinwachs D, Burton JR. Satisfaction with hospital at home care. J Am Geriatr Soc. 2006 Sep;54(9):1355-63. doi: 10.1111/j.1532-5415.2006.00855.x. PMID: 16970642.
Starting in the first quarter of 2024, GE HealthCare will begin distributing Biofourmis solutions within the US.
Hospitals have recently reported experiencing increased cost of care and readmission rates due to workforce shortages and limited bed capacities. At-home care programs are designed to support patient recovery while reducing hospital readmission rates. These programs also showed that patients are three times more likely to be satisfied with the overall experience I,VI.
Biofourmis’ FDA-cleared AI-guided algorithms and GE’s monitoring solutions can help provide efficient and personalized home care.
Biofourmis solutions enable care in person and virtually through its digital platform. The company offers clinical-grade wearable devices, at-home services orchestration technology, and nursing services.
GE HealthCare’s FlexAcuity monitoring solutions and its Mural ICU virtual care solutions are adapting to patient needs in the hospital. In offering Biofourmis virtual care-at-home solutions, GE can offer care beyond the hospital.
“Biofourmis’ demonstrated success with care-at-home solutions will extend GE HealthCare’s current inpatient monitoring portfolio to support patient care from the hospital to home,” said GE HealthCare’s global general manager of cardiology solutions, Ashutosh Banerjee. “Combining our companies’ demonstrated capabilities will help revolutionize the way we approach the patient care journey as well as help address current challenges faced by health systems including hospital capacity issues and clinical staffing shortages.”
Ross Armstrong, General Manager of Biofourmis Care, said: “Our collaboration will enable health systems and hospitals to leverage the power of technology and data in order to shape patient-focused solutions across the care continuum, no matter where the site of care is.”
Resources:
[i] Fleron, A., Krishna, A., & Singhal, S. (2022, September 19). The gathering storm: The transformative impact of inflation on the healthcare sector. McKinsey & Company. https://www.mckinsey.com/industries/healthcare/our-insights/the-gathering-storm-the-transformative-impact-of-inflation-on-the-healthcare-sector
[vi] Leff B, Burton L, Mader S, Naughton B, Burl J, Clark R, Greenough WB 3rd, Guido S, Steinwachs D, Burton JR. Satisfaction with hospital at home care. J Am Geriatr Soc. 2006 Sep;54(9):1355-63. doi: 10.1111/j.1532-5415.2006.00855.x. PMID: 16970642.